Amphiphilic comb polymers for targeted anticancer drug delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery systems face challenges in achieving targeted, stable, and efficient delivery of anticancer agents to specific tumor cells while maintaining biocompatibility and stability, as existing technologies struggle with attaching targeting moieties effectively and ensuring the stability of drug payloads.
Innovation Solution
Biocompatible comb-type polymer molecules with a hydrophilic backbone and hydrophobic branches that provide reactive functional groups for attaching targeting moieties, allowing for the encapsulation and targeted delivery of anticancer agents within the hydrophobic cores of polymer aggregates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional block copolymers are used for drug delivery, then the structure is relatively simple to synthesize, but the ability to attach targeting moieties is limited because most terminal groups are consumed in block copolymer formation
Solution Approach 1:
The polymer is divided into distinct functional segments: a hydrophilic backbone providing structural framework and terminal attachment points, and hydrophobic pendant chains providing drug solubilization capacity. This segmentation allows independent optimization of each function while maintaining overall system performance.
Solution Approach 2:
The comb-type polymer structure serves multiple functions simultaneously: the hydrophilic backbone provides structural integrity and terminal groups for targeting moiety attachment, while the hydrophobic pendant chains solubilize insoluble drugs. This multi-functionality resolves the contradiction between versatility and complexity.
2Stability of the object's composition
If hydrophobic drugs are encapsulated in micelles, then solubility is improved, but stability upon dilution is poor due to disintegration below critical micelle concentration
Solution Approach 1:
The invention creates a composite polymeric structure combining hydrophilic and hydrophobic components in a comb architecture. The hydrophobic pendant chains aggregate to form stable cores capable of holding drug payloads, while the hydrophilic backbone maintains structural integrity and prevents disintegration upon dilution, exceeding conventional CMC limitations.
3Reliability
If PEG-coated particles are used for drug delivery, then biocompatibility and evasion of reticuloendothelial system are improved, but functional groups for attaching targeting moieties are limited to chain ends
Solution Approach 1:
The polymer design concentrates functional groups at specific locations (backbone terminals) while maintaining PEG coverage on the micelle surface for biocompatibility. This local quality differentiation allows simultaneous achievement of stealth properties and targeting capability without compromise.
4Stability of the object's composition
If conventional micelles are used for drug delivery, then the structure is simple, but they suffer from disintegration when diluted below critical micelle concentration
Solution Approach 1:
The comb-type polymer structure dynamically adapts to dilution conditions: the hydrophobic pendant chains remain aggregated to maintain core stability, while the hydrophilic backbone maintains solubility. This dynamic behavior allows the micelle to remain stable across a wider concentration range compared to conventional block copolymers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enables stable, efficient, and biocompatible delivery of anticancer agents to tumor cells, enhancing the therapeutic effect by utilizing the polymer's ability to self-assemble and maintain a drug payload in a solubilized state, while allowing for specific targeting through attached moieties.
Implementation Method 1
Self-assembling amphiphilic block copolymers, which self-assemble into the more robust 'polymersomes'
Implementation Method 2
the hydrophobic compartment of an amphiphilic polymer has a tendency to self-assemble in order to avoid contact with water and to minimize the free interfacial energy of the system
Implementation Method 3
the hydrophilic blocks form a hydrated 'corona' in the aqueous environment
Implementation Method 4
encapsulation and targeted delivery of anticancer agents within the hydrophobic cores of polymer aggregates
Implementation Method 5
Amphiphilic polymer aggregates have been studied as carriers for solubilizing insoluble drugs
Implementation Method 6
attachment of antibodies or other ligands with a specific affinity for cell walls at the target site
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention provides amphiphilic biocompatible copolymers which have a hydrophilic backbone and pendant hydrophobic groups. The polymers form nanoscale molecular aggregates in aqueous environments, which have hydrophobic interiors within which anticancer drugs may be solubilized. The polymers optionally feature attached antibodies, receptor ligands, and other targeting moieties which mediate adherence of the drug-carrying aggregates to targeted cancer cells.